Antiretroviral therapy coverage for PMTCT in Mozambique
Mozambique: Antiretroviral therapy coverage for PMTCT was 82.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage for PMTCT in Mozambique, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.
Analysis
In 2024, antiretroviral therapy coverage for pmtct in Mozambique stood at 82.0%.
That represents a change of up 7.9% over ten years.
Over the whole period, antiretroviral therapy coverage for pmtct in Mozambique peaked at 83.0% in 2022 and was at its lowest, 0.0%, in 2000.
That places Mozambique 38th out of 84 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage for PMTCT in Mozambique, year by year
| Year | % of pregnant women living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 2.0% | — |
| 2004 | 4.0% | +100.0% |
| 2005 | 7.0% | +75.0% |
| 2006 | 14.0% | +100.0% |
| 2007 | 46.0% | +228.6% |
| 2008 | 45.0% | -2.2% |
| 2009 | 62.0% | +37.8% |
| 2010 | 20.0% | -67.7% |
| 2011 | 42.0% | +110.0% |
| 2012 | 65.0% | +54.8% |
| 2013 | 68.0% | +4.6% |
| 2014 | 76.0% | +11.8% |
| 2015 | 77.0% | +1.3% |
| 2016 | 71.0% | -7.8% |
| 2017 | 79.0% | +11.3% |
| 2018 | 79.0% | +0.0% |
| 2019 | 81.0% | +2.5% |
| 2020 | 77.0% | -4.9% |
| 2021 | 81.0% | +5.2% |
| 2022 | 83.0% | +2.5% |
| 2023 | 82.0% | -1.2% |
| 2024 | 82.0% | +0.0% |
Mozambique compared with similar countries
- Mozambique's 82.0% is above the median for low income countries, which is 73.0%, 1.1× the median. (22 countries reporting)
- Mozambique's 82.0% is above the median for Sub-Saharan Africa, which is 82.0%, 1.0× the median. (41 countries reporting)
Biggest year-on-year movements
Years where Antiretroviral therapy coverage for PMTCT in Mozambique changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2007 | +228.6% | 14.0% | 46.0% |
| 2011 | +110.0% | 20.0% | 42.0% |
| 2004 | +100.0% | 2.0% | 4.0% |
| 2006 | +100.0% | 7.0% | 14.0% |
| 2010 | -67.7% | 62.0% | 20.0% |
| 2005 | +75.0% | 4.0% | 7.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 18.0% | 0.0% | 62.0% | 10 |
| 2010s | 65.8% | 20.0% | 81.0% | 10 |
| 2020s | 81.0% | 77.0% | 83.0% | 5 |
Countries ranked near Mozambique
More health data for Mozambique
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.16 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 869.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18,288 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 139 (2025)
- Population ages 00-04, female, annual growth rate 1.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0823 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.92 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage for pmtct in Mozambique?
- Antiretroviral therapy coverage for pmtct in Mozambique was 82.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage for pmtct recorded in Mozambique?
- The highest recorded value was 83.0% in 2022.
- What is the lowest antiretroviral therapy coverage for pmtct recorded in Mozambique?
- The lowest recorded value was 0.0% in 2000.
- How does Mozambique rank for antiretroviral therapy coverage for pmtct?
- Mozambique ranks 38th out of 84 countries with data for 2024.
- Is antiretroviral therapy coverage for pmtct rising or falling in Mozambique?
- Over the last ten years it is up 7.9%. The long-run trend across the full record is volatile.
- Where does this Mozambique data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).